Lessina Kit
Product Images NDC 0555-9014

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lessina (NDC 0555-9014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure diagram of the active ingredients Levonorgestrel and Ethinyl Estradiol. The diagram shows the molecular framework with labeled functional groups and bonds characteristic of these compounds.*

FDA Label Image

Image 2

Chemical structure diagram of the active ingredient Levonorgestrel showing its molecular framework, including hydroxyl groups and a double-bonded carbon chain.*

FDA Label Image

Image 3

Two line graphs depicting mean serum concentrations of Levonorgestrel and Ethinyl Estradiol over time after a single dose and on Day 21 of Cycles 1 and 3. The top graph shows Levonorgestrel concentrations (pg/mL) up to 30 hours, while the bottom graph shows Ethinyl Estradiol concentrations (pg/mL) over the same time period, comparing single dose and multiple cycle data points.*

FDA Label Image

Image 4

A forest plot showing effect estimates (odds ratios or relative risks) with confidence intervals for different women's health studies from 2002 to 2017 assessing ever use and current use outcomes. The horizontal axis represents effect estimates ranging approximately from -1.5 to 2, with a vertical reference line at 1. Study names and years are listed on the left, and numerical effect estimates with confidence intervals are on the right.*

FDA Label Image

Image 5

Lessina kit packaging label showing a 4-week pill blister card with circles representing pills for each day of the week, organized in rows labeled Week 1 to Week 4 and columns labeled Sunday through Saturday. The label includes storage instructions at 20° to 25°C, the Teva Pharmaceuticals USA logo, and the NDC number 0555-9014-67. The product contains levonorgestrel 0.1 mg and ethinyl estradiol 0.02 mg tablets. Instructions indicate taking all colored pills before white pills.*

FDA Label Image

Image 6

Lessina levonorgestrel and ethinyl estradiol tablets dosing card showing a 28-day blister pack layout. The card is organized by week and day of the week with circles representing pill locations. The first three weeks contain shaded circles, the fourth week has unshaded circles. Instructions include to take all colored pills before white pills, and storage conditions are 20° to 25°C (68° to 77°F). Labeler is Teva Pharmaceuticals USA, Inc.*

FDA Label Image

Image 7

Lessina levonorgestrel and ethinyl estradiol tablets USP 0.1 mg/0.02 mg kit packaging label. The label shows 3 blister cards, each containing 28 tablets. The product is labeled as prescription only and is manufactured by Teva Pharmaceuticals USA, Inc. The label includes disclaimers about pregnancy prevention and sexually transmitted infections, along with branding for Shaping Women's Health. The NDC number 0555-9014 is prominently displayed.*

FDA Label Image

Image 8

Lessina (levonorgestrel and ethinyl estradiol) tablets USP 0.1 mg / 0.02 mg kit packaging label. The kit contains 3 blister cards with 28 tablets each. Labeler is Teva Pharmaceuticals USA, Inc. The packaging shows storage instructions and a QR code for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.